News Daily News Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions L.A. McKeown June 22, 2018
News Daily News NSAIDs Account for Large Part of Osteoarthritis-CVD Link, Study Suggests Todd Neale June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Cases of Unusual Mechanisms of Coronary Occlusion During TAVR Presenter: Omar Khalique June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Coronary Occlusion Following Self-Expandable Transcatheter Aortic Valve Replacement in Native Aortic Valve Regurgitation Presenter: Howard C. Herrmann, Fabian Nietlispach, Mohamad Lazkani, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 The New Syndrome of Delayed Coronary Occlusion (DCA) After TAVR: Frequency, Causes, and Outcomes Presenter: Azeem Latib June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Acute Left Main Stem Coronary Occlusion Following Transcatheter Aortic Valve Replacement in a Patient Without Recognized Coronary Obstruction Risk Factors Presenter: Howard C. Herrmann, Fabian Nietlispach, Roberto Spina, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Incidence, Predictors, Consequences, Prevention, and Treatment of Coronary Occlusion During TAVR: Practical Clinical Guidelines Presenter: Ariel Finkelstein June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Hybrid Beating Coronary Artery Bypass Grafting and Transcatheter Aortic Valve Replacement via Right Carotid Artery Access in a Patient With Severe Peripheral Arterial Disease Presenter: Howard C. Herrmann, Fabian Nietlispach, Marc Gerdisch, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Techniques to Reduce the Frequency of Pacemaker Implantation After TAVR Presenter: Hemal Gada June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Incidence, Predictors, and Consequences of New LBBB and New Permanent Pacemakers After TAVR Presenter: Tamim Nazif June 21, 2018
Presentation The Structural Heart Disease Summit 2018 When and How to Use Transcatheter Devices for PVL Closure After TAVR Presenter: Colin M. Barker June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Expert Commentary: PVL Assessment and Management When to Postdilate Presenter: Rebecca T. Hahn June 21, 2018
Presentation The Structural Heart Disease Summit 2018 To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures Presenter: Vinayak Bapat, Ran Kornowski, Adam B. Greenbaum June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Case Presentation: A Case of Managing Paravalvular Regurgitation During TAVR Presenter: Omar Khalique June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Impact of Paravalvular Regurgitation After TAVR on LV Geometry: A Serial Echo Study Presenter: Jung-Min Ahn June 21, 2018
Presentation The Structural Heart Disease Summit 2018 How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures Presenter: Vinayak Bapat, Ran Kornowski, Philipp Blanke June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Is Paravalvular Regurgitation After TAVR Still an Important Consideration in 2018? Presenter: Philippe Pibarot June 21, 2018
Presentation The Structural Heart Disease Summit 2018 A Growing Conundrum: Coronary Access After TAVR Technical Tips and Tricks Presenter: James B. Hermiller Jr June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization) Presenter: Torsten P. Vahl June 21, 2018
Podcast TCTMD Talking Points DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis June 20, 2018